This Review describes the current status of poststroke epilepsy (PSE) with an emphasis on poststroke epileptogenesis modeling for testing new therapeutic agents. Stroke is a leading cause of epilepsy in an aging population. Late-onset "epileptic" seizures have been reported in up to 30% cases after stroke. Nevertheless, the overall prevalence of PSE is 2-4%. Rodent models of stroke have contributed to our understanding of the relationship between seizures and the underlying ischemic damage to neurons. To understand whether acutely generated stroke events lead to a chronic phenotype more closely resembling PSE with recurrent seizures, a limited variety of approaches emerged in early 2000s. These limited methods of causing an occlusion in mice and rats show different infarct size and neurological deficits. The most often employed procedure for inducing focal ischemia is the middle cerebral artery occlusion. This mimics the pathophysiology seen in humans in terms of extent of damage to cortex and striatum. Photothrombosis and endothelin-1 models can similarly evoke episodes of ischemic stroke. These models are well suited to studying mechanisms and biomarkers of epileptogenesis or optimizing novel drug discoveries. However, modeling of PSE is tedious, is highly variable, and lacks validity; therefore, it is not widely implemented in epilepsy research. Moreover, the relevance of ischemic models to specific forms of human stroke remains unclear. Stroke modeling in young male rodents lacks clinical relevance to elderly populations and especially to women, likely as a result of sex differences. Nevertheless, because of the neuronal damage and epileptogenic insult that these models trigger, they are helpful tools in studying acquired epilepsy and prophylactic drug therapy. V C 2016 Wiley Periodicals, Inc.
based on the present models (Engel, 2001) . For idiopathic epilepsies, the etiology is unclear, but genetic factors seem to play a role. Symptomatic epilepsies fall in the category for which there is a specific insult to the brain that causes seizures. Approximately 65 million people worldwide are affected by epilepsy (Delgado-Escueta and Porter, 1999) . Some of these patients have acquired epilepsy from a secondary cause, such as a disease or brain injury from a stroke or cerebral ischemia (Luhdorf et al., 1986; Hauser, 1990 Hauser, , 1992 Hauser and HesdorVer, 1990; Hauser et al., 1991; Lambraksis and Lancman, 1998; Olsen, 2001; Myint et al., 2006) .
Stroke is a leading cause of death and disability worldwide, and most cases are of ischemic stroke. Tissue plasminogen (tPA) is the only approved, lifesaving treatment for ischemic stroke, which often limits neuronal injury. According to the American Stroke Association, in 2010, worldwide prevalence of stroke was 33 million, 16.9 million of those cases were first-time strokes. Stroke accounts for 11% of total deaths worldwide, making it the second-leading global cause of death behind heart disease. Stroke is also the leading cause of disability (Durukan and Tatlisumak, 2007; Durukan et al., 2008) . Stroke is characterized as a focal neurological deficit that results from a disruption of blood flow and subsequent ischemia to a particular area of the brain. Irreversible damage to the brain parenchyma occurs after 5 minutes of hypoxia. The most vulnerable areas of the brain are the hippocampus, cerebellum, neocortex, and other areas in the ipsilateral hemisphere. There are two categories of strokes, hemorrhagic and ischemic. Hemorrhagic strokes occur when the vessels supplying brain parenchyma rupture and intracerebral bleeding ensues. The most common areas of intracerebral hemorrhage are the basal ganglia, which is supplied by the branches of the middle cerebral artery (MCA). An ischemic stroke occurs when there is acute blockage of vessels, which leads to ischemia.
The three types of ischemic strokes include embolic, thrombotic, and hypoxic strokes. Embolic strokes occur when an embolus forms in another area of the body and travels to the cerebral vasculature to block a vessel. Thrombotic strokes occur when there is clot formation in a vessel typically over an atherosclerotic plaque. Finally, hypoxic stroke can be due to hypoxemia or hypoperfusion, which tends to affect watershed areas between two blood vessels. The overall mechanisms of stroke-induced neuronal injury are complex, including excitotoxicity, mitochondrial dysfunction, free radicals, protein misfolding, inflammatory changes, neural cell loss, injury or death of glia and astrocytes, and white matter injury (George and Steinberg, 2015) . Neurological disability is a common early-onset attribute and is often followed by a long-term increase in risk of epilepsy in some patients.
According to the International League Against Epilepsy (ILAE), poststroke epilepsy (PSE) is defined as two or more unprovoked epileptic seizures occurring at least 1 week after the stroke (Myint et al., 2006; Gibson et al., 2014) . Poststroke seizures can be early-onset or late-onset seizures. Early-onset seizures are classified as those occurring within the first week following stroke; late-onset seizures occur 2 weeks or later after stroke (Giroud et al., 1994; Lamy et al., 2003; Camilo and Goldstein, 2004; Stefan and Theodore, 2012a,b) . Early-onset seizures are caused by acute disruptions in metabolism and pathophysiology associated with stroke and are generally provoked (Kelly, 2002 (Kelly, , 2007 Myint et al., 2006) . Late-onset seizures are considered epileptic seizures because they are unprovoked and occur repeatedly. The initial stroke is followed by an epileptogenic phase that ultimately causes spontaneous seizures in 2-14% of ischemic stroke survivors (Kotila and Waltimo, 1992; Burn et al., 1997; Bladin et al., 2000; Dhanuka et al., 2001; Lossius et al., 2002 Lossius et al., , 2005 Lamy et al., 2003) .
The actual prevalence of PSE is 2.3-43% (Meyer et al., 1971; Mohr et al., 1978; Forsgren et al., 1996; Jamrozik et al., 1999) . This is partially due to a wide variability in the criteria used for stroke (ischemic or hemorrhagic), seizure occurrence, and monitoring period, as well as the sex and age of the patient population (Kilpatrick et al., 1990; Kotila and Waltimo, 1992; Giroud et al., 1994; Burn et al., 1997; Camilo and Goldstein, 2004; Kammersgaard and Olsen, 2005; Benbir et al., 2006) . Among the elderly, cerebrovascular diseases account for more than half of the newly diagnosed cases of epilepsy (Mathern et al., 1995 (Mathern et al., , 2002 . Stroke severity and hemorrhagic stroke are the most predictive factors for developing PSE (Slapo et al., 2006) . Overall, PSE generally occurs in at least 4-6% of the stroke population as evident from multiple clinical studies (Graham et al., 2013; Jungehulsing et al., 2013; Arntz et al., 2013 ). It appears that a substantial number of stroke survivors will develop epilepsy with increasing risk prior to 10 years after stroke.
This Review seeks to provide a brief overview of the experimental stroke models with an emphasis on advancing the ischemic models toward PSE modeling for the testing of new therapeutic agents. Currently, there are no specific drug therapies for preventing PSE in at-risk individuals. A greater understanding of PSE is required to facilitate the development of effective interventions for poststroke epileptogenesis or disease-modifying therapies for PSE. The main emphasis is on late-onset "epileptic" seizures that define chronic epilepsy with spontaneous seizures. Late-onset epileptic seizures are defined as recurrent seizures occurring 1-4 weeks after the stroke. The early-onset seizures that commonly occur within 1 week as a result of the acute effects of the stroke are described elsewhere (Silverman et al., 2002; Slapo et al., 2006; Kelly, 2007) .
EXPERIMENTAL STROKE MODELS Several stroke models in mice and rats have been created to mimic the disease that is experienced in stroke patients. In animals, stroke is modeled by a reversible or nonreversible blockage of cerebral vessels (Fig. 1A) . Stroke severity and outcome are typically assessed by neurological scores of sensory motor performance and histological analysis of the volume of infarction from post-mortem specimens. The various methods of causing an occlusion in mice and rats show different infarct size and neurological deficits. An ideal stroke model should have desirable characteristics such as reproducibility, clinical significance, easy methodology, and limited collateral effects akin to human ischemia (Calloni, 2006) .
In rodent models, cerebral ischemia consists of global and focal categories. Global ischemia leads to massive neuronal loss depending on the regions affected, duration of ischemia and time after stroke. Global cerebral ischemia is induced by a two-vessel occlusion and/or a four-vessel occlusion. Transient focal cerebral ischemia models, which mimic human acute ischemic stroke, enjoy widespread use, including middle cerebral artery (MCA) occlusion (Harvey and Rasmussen, 1951; Hayakawa and Waltz, 1975; Coyle, 1982; Tyson et al., 1982; Yoshimine and Yanagihara, 1983; Longa et al., 1989) , photothrombosis (Wester et al., 1992; Dietrich et al., 1993b; Markgraf et al., 1994; Schroeter et al., 2001) , and endothelin-1 (ET-1) vasoconstriction models (Robinson et al., 1991; Sharkey et al., 1993; Sharkey and Butcher, 1995; Gartshore et al., 1997; Henshall et al., 1999) . Nevertheless, the most often employed procedure for inducing ischemia is the occlusion of the MCA via a thrombus. When motor behavior is tested, the animals that survive the ischemic event show deficits on the contralateral side of the ischemia. When these ischemic areas are studied histologically, MCA occlusions form small necrotic central regions and apoptotic peripheral regions ( Fig. 1B ; Bliss et al., 2007; Caplan, 2007; Mendez-Otero et al., 2009; Balkaya et al., 2013) .
In animals, neuronal lesion evaluation and quantification following stroke are an important aspect of acute outcomes. The infarct area after stroke models is usually determined by 2,3,5-triphenyl-tetrazoluim chloride (TTC) staining at 1-5 days poststroke (Fig. 1B) . Infarct quantification is made by tracing the infarct zone of a high-contrast image of slices. It is important to ensure that the same ischemic and normal areas of the brain are available, the same relative slice is used for each brain, and only those brains that had infarcts extending throughout the thickness of the slice and into a consecutive slice are used for analysis. Therefore, infarct volume estimation is usually performed by measurement of the superior face of three to five sections in each animal. The area from the ischemic (ipsilateral) and nonischemic (contralateral) hemispheres should be measured separately to express the infarct volume of ischemic hemisphere as a percentage of the nonischemic hemisphere. In each case, the infarct area of two adjacent slices is averaged and then multiplied by the thickness of the slice, and values across all slices are added to obtain the volume of the infarct (Selvamani and Sohrabji, 2010a,b) . TTC is a colorless dye that stains healthy brain tissue red when reduced by the mitochondrial enzyme succinyl dehydrogenase (Bederson et al., 1986) . The absence of staining in necrotic tissue is then used to determine the area of a brain infarction. TTC staining is a post-mortem standard in the experimental stroke field and serves as a basic assessment tool for measuring infarct size.
There are other methods of quantification of the infarct area, such as cresyl violet (CV) staining. TTC and CV staining are routinely used methods to determine cerebral infarct volume and area. TTC and CV staining showed a high degree of correlation in infarct area and volume (T€ ureyen et al., 2004) , indicating that both methods are suitable for producing accurate measurements of cerebral experimental infarcts. Immersion staining of unfixed brain slices with TTC is a popular method to determine cerebral infarction in preclinical studies; however, it is often difficult to apply immersion TTC labeling to severely injured or soft newborn brains in rodents. A recent report shows the promise of an in vivo TTC perfusion labeling method, which is based on an osmotic opening of blood-brain barrier (BBB) with mannitol pretreatment (Sun et al., 2012) . In addition, most silver stains are helpful to highlight the amount of degeneration in the ischemic sections. The sophisticated DWI/MRI or perfusion-weighted MRI is a good measure of the infarct size as a result of ischemic injury. The noninvasive MRI methods are very helpful in monitoring the progression of ischemic injury and repair.
MCA Occlusion Model
The most popular approach for inducing stroke is occlusion of the middle cerebral arteries (Rossmeisl et al., 2007) . In these strokes, subcortical structures are damaged first, followed by the cortical structures. The most damaged structures are cortex and striatum. This mimics the pathophysiology seen in human striatocapsular infarcts in terms of extent of damage and structures involved (Rossmeisl et al., 2007) . These striatocapsular infarcts damage a great extent of the basal ganglia and the surrounding white matter tissue (Rossmeisl et al., 2007) . Thromboembolic stroke has been described as an acute focal paradigm (R.L. Z. Zhang et al., 1997) . One of the methods to induce MCA occlusion is by injecting a preformed fibrin clot into the internal carotid arteries. Because of the large size of the preformed fibrin clot, this model is used with rats, most often unilaterally. Consequently, a pronounced ischemia is created in the territory supplied by the ipsilateral MCA. Because the vessels can naturally break down fibrin, this model provides a good timeline for fibrin clot breakdown and reperfusion (Wang et al., 2001a) . At 3 hr after the fibrin clot injection, all microvasculature supplying the cortex is reperfused, but striatum deficits in perfusion are still present (Wang et al., 2001b) . After 24 hr, all microvasculature in the cortex and striatum has been reperfused (Wang et al., 2001a) . In the preformed fibrin clot model, downstream branches are also occluded by the clot fragment (Heye et al., 1992; Overgaard et al., 1994; Busch et al., 1998; Wang et al., 2001b) .
Fibrin microemboli can be used to induce stroke in mice. This model varies from other embolic models in a multitude of ways. Because these microemboli are much smaller (2.5-3 lm) than previous clots (200 lm to millimeters), they are able to reach the microcirculation (Atochin et al., 2004) . One way in which this model differs from other embolic models is that one can vary the dose of the fibrin microemboli, which directly influences the extent of the cerebral damage (Murciano et al., 2002; Atochin et al., 2004) . With a moderate dose of the fibrin microemboli, a reproducible and momentary reduction in cerebral blood flow is seen (Atochin et al., 2004) . However, blood flow is reestablished naturally reflecting physiological fibrinolysis (Atochin et al., 2004) . A combination of transient MCA occlusion and common carotid artery is another model to produce consistent cortical infarcts with little damage to subcortical structures and hippocampus (Aronowski et al., 1997; Kelly et al., 2006) . This model is designed to simulate the aspects of human strokes.
MCA Occlusion by Filament
The reversible MCA occlusion model has been studied widely because of its similarity in recanalization of a thrombosed or embolized vessel by tissue plasminogen activator (t-PA; Longa et al., 1989; Garcia et al., 1993; Chiang et al., 2011; Bake et al., 2014) . In this model, the MCA is occluded with a filament suture that is accelerated along the internal carotid artery through the external carotid artery until it reaches the MCA in the skull (Fig.  1A) . Once the suture is 10 mm past the bifurcation point of the common carotid, the suture is tied off and held in place for varying amounts of time and then removed for reperfusion to occur (Chiang et al., 2011) . This model allows a less invasive and simpler approach to occlude a cerebral vessel compared with the craniotomy models (Liu et al., 2009a) . This model is typically used in rats but, with advanced surgical skill, can be performed in mice as well. Mice have been used sparingly as experimental models because, unlike rat models, mouse MCA occlusion is technically more challenging and unreliable because of high mortality, lack of functional behavior tests, and the need for tedious blood flow monitoring. This model has been used to learn more about ischemic stroke for many years; however, the development of infarction within the territory supplied by the MCA is not well understood . Thus, there are variances in infarct size resulting from disagreements over the proper time to measure the impact of therapeutic agents (DeVries et al., 2001; Culmsee et al., 2005; Hoyte et al., 2006) .
Patients who are older have an increased mortality rate as well as more functional deficits following an ischemic incident (Rojas et al., 2007) . Even though it would be more clinically relevant to perform MCA occlusions on aged rats and mice, limited amounts of studies have used older animals. As animals age, several physiological and chemical changes arise (McCullough et al., 2005; Anyanwu, 2007; Li et al., 2007) . In general it is more challenging to complete MCA occlusions in older rodents. As they age, they become heavier, accumulate greater levels of visceral fat, and have higher mortality postocclusion (Liu et al., 2009b) . Aged animals also have more rigid vessels, causing insertion and acceleration of the filament to become more challenging. . Therefore, one of the drawbacks to the MCA occlusion model is its lack of application to older animals, which would be more clinically applicable .
Over the past 20 years, the intraluminal filament stroke model has been employed extensively (Yamashita et al., 1997; Li et al., 1999; Reglodi et al., 2000; Yanamoto et al., 2001; Gerriets et al., 2003) . Most human strokes are smaller, from 28 to 80 cm 3 (Saver et al., 1999; Carmichael, 2005) . The percentage of infarcted tissue in relation to the total volume of the ipsilateral hemispheric volume is from 5% to 14% (Lyden et al., 1994) . In malignant human brain infarctions, which make up 10% of human stroke cases, this percentage is higher, approximately 39-47% (Oppenheim et al., 2000; Foerch et al., 2004) . Most recent publications that use a mouse MCA occlusion model report an infarct volume affecting 21-45% of the ipsilateral hemisphere (Belayev et al., 1999; Boutin et al., 2001; McColl et al., 2004) . Most experimental MCA occlusion models appear to be optimized for greater infarct outcomes than human stroke. Thus, most of the mouse MCA occlusion models do not resemble the typical case of human stroke but instead resemble more closely a malignant human brain infarction (Carmichael, 2005) .
Cortical Photothrombosis
Photocoagulation of the common carotid artery is another method used to induce perfusion deficits in the MCA. This technique is used more often in mice; however, it can also be performed in rats. There are two distinct techniques of photothrombosis, cortical photothrombosis and direct photothrombosis of the internal carotid artery. The process behind the cortical thrombosis model requires a laser-driven photochemical technique, which results in direct peroxidation of the endothelial membrane, resulting from single molecular oxygen (Lozano et al., 2007) . The technique is generated by the photosensitive dye rose Bengal (Rosenblum and El-Sabban, 1977; Watson et al., 1985) . Rose Bengal is injected into the animal intraperitoneally or intravenously and activated by an external light source that penetrates the translucent skull. Oxygen is the only photoproduct when rose Bengal or erythrosine B is incorporated as the characteristic type II photosensitizing dye (Watson et al., , 2002 . The photochemically induced endothelial damage selectively attracts platelets, which then degranulate and start a process of aggregation (Lozano et al., 2007) . This results in a bulky but nonobstructive platelet thrombus inside the ipsilateral common carotid artery. The thrombus delivers a regular stream of emboli, which creates multiple downstream embolic infarcts (Dietrich et al., 1993a,b) . Photochemically induced thrombus models require an intact hemostatic system, which interacts with the arterial endothelium, thus making it thrombogenic by photochemical reaction (Lozano et al., 2007) .
Although the photothrombotic model resembles some aspects of the human stroke, there are issues with occlusion reproducibility and consistency (Dietrich et al., 1988; Joseph et al., 1991; Lozano et al., 2007) . As is seen in human patients with atherosclerotic disease who have varying sizes of infarcts in different locations, rodents that experience nonocclusive arterial injury may not have ischemic injuries in the same territories or even the same extent of cerebral damage (Lozano et al., 2007) . Furthermore, vascular anatomy along the embolus path deviates among individuals and species; these small changes in blood flow and recanalization time could possibly vary the size and territory of embolic infarcts (Valeri et al., 1987; Dietrich et al., 1987; Faraday and Rosenfeld, 1998; Johnston et al., 1994; Wolberg et al., 2004; Liebeskind, 2005) . In terms of clinical relevance, the photocoagulation of the internal carotid artery is applicable to thromboembolic stroke populations, accounting for 75% of cerebral vessel occlusions (Lozano et al., 2007) .
ET-1 Vasoconstriction
Focal ischemic lesions can also be induced by stereotaxic injections of ET-1 in the gray or white matter. ET-1, isolated from aortic endothelial cells, is a peptide that has a strong and long-lasting vasoconstrictive effect in various vascular beds (Yanagisawa et al., 1988; Rubanyi and Polokoff, 1994) . In the brain, ET-1 acts on a multitude of ET receptors present throughout the CNS on the vascular endothelium and also present on astrocytes (Venance et al., 1998 ), microglia (McLarnon et al., 1999 , and neurons (Rubanyi and Polokoff, 1994) . Endothelin type A receptors in the rat CNS are located on smooth muscle cells of pial arteries of the cerebral cortex. Endothelin acts on arteries as a potent vasoconstrictor. For instance, high doses of ET-1 directly injected into the brain parenchyma of rats have been shown to reduce striatal blood flow by 60% in 20 min while leaving systemic blood flow unaffected (Fuxe et al., 1992) . In addition, topical administration of ET-1 directly on the MCA has been shown to decrease cerebral blood flow in rats and cats (Mima et al., 1989; Robinson et al., 1991) .
The stereotaxic injection of ET-1 for MCA occlusion is typically used in rats and not mice because mice lack the ET-1 receptor, so injection would produce little to no decrease in cerebral blood flow. ET-1, when injected in white or gray matter, typically reduces cerebral blood flow within 1 hr after the injection (Hughes et al., 2003) . This decreased cerebral blood flow typically lasts for 7 hr or more, depending on the dose and site of infusion (Hughes et al., 2003) . When cerebral blood flow is altered, effects from other insults besides ischemia can come into play. Usually when cerebral blood flow is reduced, the BBB can be compromised; the amount of damage to the BBB depends on the duration and extent of the reduction of blood flow (Hallenbeck and Dutka, 1990) . When ET-1 is directly injected onto the striatum, no breakdown of the BBB is seen. This is a beneficial component of this model because the model will not be confounded by the involvement of vasogenic edema in lesion formation (Hughes et al., 2003) . However, cell loss is still observed and contributes to cytotoxic edema from the decreased cerebral blood flow (Hughes et al., 2003) . There are minimal exogenous effects to the animal in this model because the BBB is not destroyed. This model serves as a good method for understanding the mechanisms behind ischemia-induced cytotoxic edema in the gray and white matter areas. It is also beneficial in analyzing the clinical potential of novel treatments that preserve axonal integrity.
Sodium Laurate Injection
Sodium laurate injected directly into the carotid artery can also model stroke in animals and is typically used in rats. Arterial injection of sodium laurate is known to cause tissue necrosis in the downstream arteries, leading to platelet aggregation, platelet adhesion, and finally to an obstructive thrombus (Kumada et al., 1980) . When injected into the internal carotid artery, sodium laurate causes lacunar infarcts, which are downstream infarcts resulting from the obstruction of the perforating braches of the major cerebral vasculature (Fisher, 1982; Kappelle and Gijn, 1986; Toshima et al., 2000) . This model presents several significant advantages over other models. The main arteries occluded via endothelial injury and consequential thrombus formation are the perforating arteries, which allows researchers to study lacunar infarcts properly (Toshima et al., 2000) . Additionally, minor cerebral infarcts from microthrombotic obstructions, in combination with neurological abnormalities, can be induced (Toshima et al., 2000) . Specifically, this model leads to small arterial wall injuries via microthrombi, providing an excellent platform for learning more about the treatment and pathophysiology of minor cerebral infarcts (Toshima et al., 2000) .
Spontaneous Stroke Model
Another stroke model that is often used in experimental interventions is the spontaneous stroke model. In this model, spontaneously hypertensive stroke-prone rats are used, which naturally develop a multifaceted type of cerebrovascular pathology (Okamoto et al., 1974; Volpe et al., 1998) . For this specific rat strain, brain vascular disease is induced by a hypertensive state and is magnified by the introduction of a low-protein, low-potassium, and high-sodium diet, also referred to as the Japanese permissive diet (Yamori et al., 1984; Sironi et al., 2001 Sironi et al., , 2003 Sironi et al., , 2004 . Moreover, it has been reported that, compared with other surgical stroke models such as MCA occlusions, brain damage in the spontaneous stroke model results from breakdown of the BBB in the absence of cytotoxic edema (Huber et al., 2001; Guerrini et al., 2002) . It is known that in several inflammatory conditions the BBB is broken down (Abbot, 2000; Huber et al., 2001 ). Thus, brain injury is possibly triggered by the extravasation of bloodborne cells that have greater BBB penetrability (Couraud, 1998; Gigante et al., 2003) . This strain of rats has alterations in the vessel walls that explain the BBB breakdown. In terms of clinical relevance, many neurological disorders with strong inflammatory mechanisms such as stroke, Alzheimer's disease, and multiple sclerosis have been shown to include changes in concentration and composition of cerebrospinal fluid (CSF) proteins along with BBB integrity (Couraud, 1998; Kappos et al., 1999; Abbott, 2000; Berzin et al., 2000; Davidsson et al., 2001 ).
POSTSTROKE EPILEPTOGENESIS
There are some strong predictors for poststroke epileptogenesis. Stroke severity and hemorrhagic stroke appear to be the two most consistent factors (Olsen, 2001; Slapo et al., 2006; Kelly, 2007) . According to the Oxfordshire community stroke project, 11.5% of patients with stroke are at risk of developing poststroke seizures within 5 years (Burn et al., 1997) . Another study was conducted in which Hauser and colleagues (1993) analyzed the incidence of all unprovoked seizures and epilepsy in Rochester, Minnesota, during the years . From all the cases analyzed, they found that cerebrovascular disease was a factor in 11%. The increased incidence of PSE has been well documented; there is a strong need for therapeutic treatments specific to this condition. Although predicting who will have seizures after a stroke is challenging, some risk factors are correlated with a greater frequency of poststroke seizures such as stroke severity, cortical damage, degree of ongoing disability after a stroke, hippocampal involvement, primary neurological deficit, and involvement of several territories of the brain (Browne and Holmes, 2001) . In cases of subarachnoid hemorrhages, the likelihood of poststroke seizures is influenced by EEG abnormalities, structural brain lesions, and partial epileptic seizures. Despite growing awareness of stroke as a major cause of epilepsy, especially among the aged, research is limited to identifying a clinically relevant model, which is essential to understanding poststroke epileptogenesis. A limited array of models such as MCA occlusion and photothrombosis are facilitating poststroke modeling in animals (Kelly, 2007) .
Mechanistic Insights of PSE
Mechanisms of PSE and its risk factors are poorly studied, mainly because of limited developments in animal modeling of PSE. Generally, PSEs occur in three stages (Fig. 2) . The first stage is the original brain insult from stroke; the second stage is the latent period in which, although no seizures occur, molecular and cellular changes in the brain are occurring; and the third stage is the presence of recurring seizures (Pitkanen et al., 2007; Reddy, 2013) . The development of epileptogenesis is thought to be a step function of time after the brain injury, with a latent period between the brain injury and the first unprovoked seizure. Various studies indicate that, during epileptogenesis, vast cellular changes occur, for example, gliosis, cell death, neurogenesis, axonal and dendritic plasticity, angiogenesis, and rearrangement of extracellular matrix (Jutila et al., 2002) . These changes typically occur in the latent period after an initial brain insult. Thus, the latent period represents a critical window for effective "antiepileptogenic" interventions for preventing epilepsy in people at risk.
The pathophysiology of PSE is complex and multifaceted (Fig. 3) . Stroke is a common epileptogenic injury among the elderly. The main predictors for the development of PSE are stroke severity, cortical stroke, and hemorrhagic stroke (Slapo et al., 2006) . Based on the age and predictive factors, the potential mechanisms underlying the PSE include 1) loss of neurovascular unit integrity, 2) hypoxia and metabolic dysfunction, 3) BBB dysfunction, and 4) glutamate excitotoxicity (Sun et al., 2001 (Sun et al., , 2002 Kessler et al., 2002; Silverman et al., 2002; Myint et al., 2006) . The disordered cerebral metabolism and perfusion leading to chronic neuronal injury and inflammation can trigger progressive epileptogenic changes (Fig. 3) . Neuronal injury or neurodegeneration at the infarction sites or surrounding areas, including the penumbra, can activate the progressive epileptogenic process, including excitatory neuron axonal sprouting. Numerous studies have been performed to understand better the mechanisms behind these various possibilities. Analysis of the characteristics of cortical damage shows that extensive lesions with cortical involvement tend to be more frequent in patients with PSE (Gupta et al., 1988; Ryglewicz et al., 1990) . Complex changes in neuronal excitability and gliotic scarring are most probably the primary causes of PSE seizures (Myint et al., 2006) . Such common epileptogenic pathways are supported by the clinical studies that show PSE occurring in patients with ischemic and hemorrhagic strokes. Furthermore, sustained inflammation from secondary triggering factors for stroke plays a critical role in epileptogenesis.
A cascade of devastating acute injuries contributes to seizures after stroke. The function of the BBB, or neurovascular unit that regulates the passage of blood constituents to brain parenchyma, is compromised by stroke and reperfusion. The neurovascular unit comprises the microvascular endothelium and neuronal and glial cell elements (astrocytes) in close proximity. The most consistent and well-characterized risk factor for seizures in both cerebral infarction and hemorrhage is cortical involvement (Arboix et al., 1997; Burn et al., 1997; Beghi et al., 2011) . Cortical infarcts can cause a twofold increase in risk of seizure after stroke; cortical hemorrhage has an almost threefold increase in risk (Bladin et al., 2000) . Hemorrhagic stroke was a significant risk factor for seizures compared with ischemic stroke. Patients with lateonset seizures were at greater risk of epilepsy than those with early-onset seizures (Bladin et al., 2000; Bladin and Bornstein, 2009 ). Stroke severity is one of the bestsupported risk factors in the PSE population. This is consistent with multicenter studies that link more damaging strokes to a higher risk of developing PSE (Arboix et al., 1997; Burn et al., 1997; Bladin et al., 2000) . Accordingly, in the cerebral infarction, larger strokes or multiple lesions, severity of the disability or neurological deficit, and hippocampal involvement are associated with a . PSE development can be described in three distinct stages, 1) the initial stroke injury (epileptogenic event), 2) the latent period (silent period with no seizure activity), and 3) chronic period with spontaneous recurrent seizures. Although the precise mechanisms underlying PSE remain unclear, the focal stroke damage activates diverse signaling events, such as inflammation, oxidation, apoptosis, epigenetic neurogenesis, and synaptic plasticity, which eventually lead to structural and functional changes in neuronal networks with enduring predisposition to synchronized hyperexcitability and seizures.
higher risk of poststroke seizures (Lancman et al., 1993; Bladin et al., 2000; Browne and Holmes, 2001 ). Additional factors such as sex, age, and disease states can also affect the risk and prognosis of PSE (Gibson, 2013; Sohrabji et al., 2015) .
Experimental Aspects of PSE and Outcome Analysis
Experimental aspects of PSE are very similar to chronic epilepsy models, such as traumatic brain injury (TBI) or post-SE epileptogenesis (Pitk€ anen et al., 2007; Losher and Brandt, 2010) . The stroke induction serves as the initial precipitating injury, akin to mild to moderate TBI. After stroke, animals are monitored for electrographic and behavioral seizures or seizure-like activity for several weeks or months. The primary outcome measurements include 1) the latent period to first (late-onset) spontaneous seizure, 2) incidence of animals with spontaneous recurrent seizures, 3) frequency of spontaneous seizures, and 4) severity and duration of spontaneous seizures. The surrogate measurements include preictal and interictal spikes, ripples, and seizure threshold. The secondary parameters include 1) behavioral alterations (learning and memory and other behavioral tasks) and 2) neuropathology of brain sections (neurodegeneration, neuronal sprouting, and neurogenesis).
Electrophysiological events play a key role in the progression of brain injury from regions of primary ischemic or traumatic insult to adjacent regions of secondary injury. EEG seizure activity can occur in the absence of overt clinical manifestations of stroke-induced seizures. Indeed, it is evident that distinct episodes of generalized seizure discharges occur in a high proportion of MCA occlusion-injured animals but without overt manifestations or disturbance of normal motor behavior. Therefore, continuous EEG monitoring is a critical component of the overall experimental design for PSE. Various video-EEG montages are used to acquire EEG signals depending on the model and study design. EEG recording electrodes are implanted immediately after stroke induction or a few days after ischemic injury. Video recordings are very helpful to monitor behavioral seizures and the overall activity of the poststroke animals. There are two phases of poststroke monitoring for seizure activity, acute-phase and chronic-phase monitoring. In acutephase monitoring, animals are returned to recording chambers immediately after the ischemic procedure, and continuous EEG recordings are taken for 72 hr or more. Animals are observed carefully for signs of tonic/clonic motor convulsions and other abnormal behaviors. Epileptiform discharges serve as indicators of hyperexcitability or synchronous seizure activity. Behavioral manifestations of seizures are scored by the Racine scale of 0-5 (Racine, 1972) . Electrographically, seizure activity can be detected by both the ipsilateral and the contralateral cortical electrodes. Focal discharges are often evident from the ipsilateral electrode.
During the chronic phase, continuous EEG recording is made for the full duration of the study, from 1 to 12 months after stroke. Apart from EEG, concurrent behavioral monitoring is critical to discern the artifacts of electrographic events and also to compare the EEG and behavior or motor seizure activity. Continuous long-term monitoring of seizure activity is achieved by commercially available wireless video-EEG systems or custom-made tethered systems. Development of spontaneous seizures is most accurately identified by continuous video-EEG recordings 4-12 months following stroke in rats. Intermittent recordings at 1, 3, 6, and 12 months are not ideal because of the unpredictable nature of seizure occurrence. Such intermittent monitoring may lead to false-negative outcomes. The identification of a spontaneous seizure is generally determined based on analysis of the EEG files. EEG activity that differs from the background (twofold or more) with a clear onset and offset is defined as an EEG seizure. A typical spontaneous seizure will last from 20 to Fig. 3 . Potential mechanisms of poststroke epileptogenesis. Epileptogenesis after stroke stems from multifaceted pathways and signaling systems in the brain, including chronic neuronal injury or neurodegeneration and neuroinflammation. Late-onset "epileptic" seizures after stroke are symptomatic manifestations of profound neuroanatomical changes in neural networks that control synchronized hyperexcitability. Such changes are evident progressively as a result of the devastating acute neurovascular dysfunction and excitotoxicity that occur immediately after stroke. 50 sec, with a high-amplitude, high-frequent rhythmicity. An electrographic seizure is defined as epileptiform discharge or paroxysmal discharge with rhythmic repetitive waveforms that last for at least 5 sec, have a clear beginning and ending, and show temporal evolution in amplitude and frequency. If an electrographic seizure occurs, the severity of the behavioral seizure is scored based on the video image by an independent observer or automated software. Number, duration(s), and frequency of seizures during the monitoring period will serve as primary indicators of epileptogenesis. PSE modeling is interpreted as positive if there is an enduring alteration in the brain (stroke) or predisposition to seizures with at least two spontaneous seizures. Finally, the extent of neurodegeneration and aberrant axonal sprouting are assessed by histological analysis. In many PSE models, there is mossy fiber sprouting in the inner molecular layer of the dentate gyrus, even though the density can vary between models or duration of monitoring period.
Analysis of previous reports will lead to answers to critical questions such as: Do animals develop spontaneous seizures after transient ischemia? How should epileptic seizures (onset time, incidence, seizure types, and behavioral correlates) in animal models of stroke be defined? What are critical approaches and designs for detecting epileptogenesis and spontaneous seizures? Are epileptogenic abnormalities linked to axonal plasticity in the hippocampus? Is there a temporal correlation between extent of injury and late-onset seizures? What are the experimental complications or variables to be considered in aged animals? Answers to these and many other questions will facilitate the identification of molecular targets for antiepileptogenic treatments, the design of treatment paradigms, and the relevance of current models to human epilepsy.
Experimental PSE Models
A limited variety of experimental stroke models has been used to check for epileptic seizures by EEG recording or behavioral monitoring. Early-onset seizures were apparent in a majority of stroke models, such as MCA occlusion (Kudo et al., 1982; Lu et al., 2001; Wang et al., 2001a,b; Hartings et al., 2003; Williams et al., 2004) . These seizures are due mostly to an ischemia-induced response rather than true epileptic events. A detailed mechanistic description of such early-onset seizures is beyond the scope of this Review. The field of PSE is still in its infancy because of the many challenges in successful PSE modeling. There are very limited reports of longterm follow-up for detecting recurrent epileptic seizures (Pitkanen et al., 2007) . The general features of selected PSE models are outlined in Table I , and the chronic PSE animal studies are summarized in Table II. PSE modeling is implemented mostly in young male rodents. This is another major issue for lack of clinical relevance to aged population, especially to women, because of potential sex differences in stroke outcomes. Age and sex differences are much more prevalent in stroke and also are widely recognized in rodent models (Bake et al., 2014; Giorgi et al., 2014; Koppel and Harden, 2014; Sohrabji et al., 2015) . Stroke studies have shown that young females have a smaller infarct and better cerebral blood flow than age-matched males (Alkayed et al., 1998) . Young females sustain a smaller infarct compared with young males or aged female mice (Liu et al., 2009 ); however, aging reverses these sex differences, such that aged females showed significantly more mortality and poorer stroke outcomes compared with older males (Manwani et al., 2011) . Sex differences have also been noted at middle age, when adult female rats have smaller infarcts than middle-aged females (Selvamani and Sohrabji, 2010) . Therefore, selection of a battery of models in both genders and in aged rodents is important to gaining clinically relevant insights from PSE modeling.
MCA Occlusion PSE Model
The MCA is the most commonly affected vessel in stroke (Mohr et al., 1986) , and its occlusion is associated with late-onset seizures and epilepsy Sacquegna et al., 1984) . The MCA occlusion model of stroke has been used to investigate whether the initial ischemic injury is followed by an epileptogenesis phase and eventually by recurrent spontaneous seizures in (2007) rats (Karhunen et al., 2003 (Karhunen et al., , 2006 Pitkanen et al., 2005; Kelly et al., 2006; Miller et al., 2013) . Although stroke as an injury factor for epilepsy is widely recognized, the experimental PSE modeling is highly disappointing, with little or no evidence of poststroke epileptic seizures. It was found that combined occlusion of the MCA and the common carotid artery does not induce epilepsy in rats during a 6-month follow-up . Similar findings were obtained with the intraluminal filament model of MCA occlusion followed by 10 months of video-EEG monitoring (Karhunen et al., 2003) . However, animals had a long-lasting sensorimotor deficit and spatial memory impairment. It is unclear whether MCA stroke is associated with progressive change in seizure threshold and epileptiform-like activity, which are indices of subclinical epileptogenic process.
To create a better PSE model, MCA occlusion has been implemented in an age-dependent fashion using young adult (4 months old), middle-aged (12 months old), and aged (20 months old) rats (Miller et al., 2013) . By using permanent and transient (3 hr) unilateral MCA and common carotid artery occlusion coupled with longterm video-EEG monitoring, Miller et al. have assessed EEG and behavioral seizures associated with poststroke epileptogenesis. Approximately 14% animals demonstrated seizure activity after MCA/common carotid artery occlusion, including middle-aged and adult animals. The latency for first spontaneous seizure was 316 days. However, there was no evidence of mossy fiber sprouting in the Timm staining of these animals, indicating that the hippocampus may not be affected by MCA/common carotid artery stroke. Mossy fiber sprouting is a hallmark morphological feature of limbic epileptogenesis in rodent epilepsy models (Rao et al., 2006; Reddy and Kuruba, 2013) .
Rat models of MCA occlusion are the standard models to induce cerebral ischemia and infarction. In rats, distal MCA occlusion does not produce consistent infarction because of the vascular anatomy. The hippocampus can lie within the region of ischemic injury because it is perfused by the PCA that can be blocked by MCA occlusion (Del Zoppo, 1998) . In contrast, the hippocampus is generally unaffected by the MCA occlusion because of differences in vascularity (Kelly, 2007) . Although the hippocampus is not the primary site of ischemic injury with MCA occlusion, a long-term neurodegeneration is evident within this region from such an injury. Nevertheless, the overall relevance of MCA occlusion model to PSE modeling is unclear.
ET-1 PSE Model
In another PSE model, the ET-1 stroke paradigm was used to check for poststroke epileptic seizures (Karhunen et al., 2006) . MCA occlusion was induced by intracerebral injection of ET-1 (120 pmol), and rats were followed for 6-12 months. Intermittent video-EEG recordings indicated late seizures in one of eight rats during 6 months of video-EEG recordings and in zero of 18 rats during 12 months of video-EEG recordings (Karhunen et al., 2006) . However, epileptiform interictal spiking was observed in 35% of animals (N 5 26). There was no evidence of mossy fiber sprouting. Morris water maze test revealed no apparent differences in memory function. Thus, production of MCA stroke by intracerebral ET-1 injection appears to be a weak trigger for epileptogenesis in adult rats. It remains unclear whether these animals displayed any hypersusceptibility to chemoconvulsants or decreased seizure thresholds, which may reflect their hyperexcitability status. Because a higher dose of ET-1 can cause a greater infarction, it is likely that a high-dose regimen might lead to a positive PSE occurrence.
Recently, we studied the long-term epileptic seizures in young and aged female rats after stroke induced by MCA occlusion (Park et al., 2016) . MCA occlusion was induced by intracerebral injection of ET-1 (600 pmol) in adult (6 months, cyclic) and middle-aged (11 months, acyclic) female rats. Animals were recorded for the occurrence of behavioral and electrographic spontaneous seizures by a continuous 24/7 video-EEG system for 1 week at 2, 4, 6, 8, 10, and 12 months. Epileptiform "seizurelike" discharge were detected in 25% (one of six adults) and 40% (two of five middle-aged) of rats at 4 months and in 50% (one of two adult) and 33% (one of three middle-aged) at 6 months after stroke; spontaneous seizures were not evident at 8, 10, or 12 months after stroke (Park et al., 2016) . Overall, these results indicate that MCAO-induced stroke is a potential epileptogenic trigger with extremely low incidence, but this condition may be sensitive to a subsequent hit or secondary brain injury.
Photothrombosis PSE Model
The cortical photothrombosis model has been used to check for the development of epileptogenesis and memory deficits (Kelly et al., 2001; Liu et al., 2002; Kharlamov et al., 2003 Kharlamov et al., , 2007 Karhunen et al., 2007) . There was some evidence of epileptogenesis after cortical photothrombotic lesion in rats. In contrast to MCA occlusion models, a model of small cortical photothrombotic lesions with rose Bengal dye induces epilepsy in up to 50% of animals (Kelly et al., 2001; Kharlamov et al., 2003) . These studies show that PSE can be induced in rats using cortical photothrombosis. A recent study has confirmed these findings (Kharhunen et al., 2007) . In this study, spontaneous seizures were recorded by intermittent video-EEG monitoring at 2, 4, 6, 8, and 10 months for 7-14 days (24 hr/day). Epileptic seizures were detected in 18% of rats that received photothrombosis. The average seizure frequency was 0.39 seizures per recording day, and mean seizure duration was 117 sec. Spatial learning and memory assessment in rats with photothrombotic lesions show evidence of cognitive impairment. Development of epilepsy was accompanied by light mossy fiber sprouting in the inner molecular layer of the dentate gyrus, indicating that the hippocampus might be affected by PSE. These findings suggest that photothrombotic stroke in rats is a viable animal model for investigating the mechanisms of poststroke epileptogenesis.
CLINICAL PROSPECTS
Although epileptic seizures are a well-known complication of stroke, data are limited regarding the long-term rate of seizures in patients who have a stroke. Recently, Merkler and colleagues (2016) have analyzed the longterm risk of seizures following stroke to reaffirm the likelihood of developing seizures after stroke. They examined hospital visits from 2005 to 2013 in California, Florida, and New York and identified over 600,000 patients with stroke, finding that 15% of stroke patients had a seizure after an average of 3 years of follow-up. Patients who have hemorrhagic stroke may face an even higher rate of seizures.
The primary therapeutic interventions for PSE remain antiepileptic drugs (Hauser, 1992; Brodie et al., 1999; Reddy, 2014) . The recommended first-line antiepileptic treatments are sodium valproate, topiramate, lamotrigine, and carbamazepine. A recent population-based study demonstrates that valproic acid treatment to lateonset PSE patients shows better seizure control than phenytoin (Huang et al., 2015) . Other monotherapies include phenobarbital and clonazepam along with phenytoin, which is used as an alternative in older patients. With these drug treatments the main limitation is drugassociated sedation. For older patients, treatment has to be monitored more closely because of hepatic enzyme induction by antiepileptic drugs, which can lead to drug interactions (Myint et al., 2006; Reddy, 2010) . Additionally, the effects of aging on drug clearance could lead to higher levels of toxic effects.
Seizure prophylactic treatment is advised by the Stroke Council of American Heart Association for acute cases of subarachnoid and intracerebral hemorrhages (Broderick et al., 1999) . Some of these patients who have deep cerebellar or subcortical lesions have a lower chance of developing recurrent seizures and do not need regular prophylactic treatment. On the contrary, patients who elicit seizure incidents greater than 2 weeks poststroke have an increased chance to develop recurrent seizures and should be placed on regular prophylactic treatment. Furthermore, seizures that start early have to be therapeutically treated for 1 month, and if during the treatment seizure activity is absent the medicine can be stopped (Qureshi et al., 2001) . In terms of daily living, the proper precautions that are taken with epileptic patients are also taken with patients who have PSE or poststroke seizures, for example, routine follow-up visits to determine drug side effects, stepwise increment of dose regimen to maintenance dose, and supervision of activities such as cooking, exercising, and swimming (Kotila and Wiltimo, 1992; Kalpatrick et al., 1990; Myint et al., 2006) . When diagnosing these patients it is imperative that alternative differential diagnoses be considered because the outward cause of the seizures, for example, stroke, could be disguising the real cause of the seizures, such as metabolic, neurological, and cardiovascular issues (Suman and Das, 2003; Myint et al., 2006) .
CONCLUSIONS AND FUTURE DIRECTIONS
Stroke is a major cause of epilepsy and a substantial proportion of patients with stroke develop PSE, particularly among the elderly. The long-term risk of seizure after stroke appears temporally similar to that after TBI, which is widely recognized as a strong long-term seizure risk factor. The prevalence of PSE varies between 3.3% and 13%, depending on factors such as onset of the study and duration of the follow-up. There are two predictive factors for developing PSE, stroke severity and hemorrhagic stroke, among other related factors. The pathophysiology of PSE is complex and multifaceted, most likely involving chronic neuronal injury and inflammation. As with symptomatic epilepsy, PSE is treated successfully with standard antiepileptic drugs. However, there is no approved therapy for preventing PSE. There is an unmet need for drugs that truly prevent the development of PSE ("antiepileptogenic agents") or alter its natural course to delay the appearance or severity of epileptic seizures ("disease-modifying agents") in people at risk for epilepsy. Understanding the causes of the epilepsies and prevention of epilepsy and its progression are identified as top priorities in the 2014 National Institutes of Health NINDS Benchmarks for Epilepsy Research. A clinically relevant, valid approach to poststroke modeling is essential for advancing the goal of preventing epilepsy in people with a stroke history. A key problem in understanding the PSE is that very little is known about poststroke epileptogenesis in animal models. A limited array of stroke modeling, including MCA occlusion, photothrombosis, and ET-1 paradigm, is facilitating PSE modeling in animals. Kelly and collaborators (Kelly et al., 2001 Kelly, 2002 Kelly, , 2006 Kelly, , 2007 and other workers such as Pitk anen and coworkers (Karhunen et al., 2003 (Karhunen et al., ,. 2006 Pitkanen, 2005 Pitkanen, , 2007 have made apparent contributions to understanding poststroke epileptogenesis.
Epidemiologic data indicate that TBI and stroke are a cause of epileptogenesis among adults and the elderly. Unlike TBI, which triggers epilepsy in up to 53% of patients, stroke accounts for epilepsy development in up to 15% of patients with ischemic stroke. Even in rat models of stroke and TBI, there are clear differences in the fraction of animals developing epilepsy and the latent period to the first spontaneous seizure (Pitk€ anen et al., 2007) . The latent period ranges from 1 to 6 months in TBI and stroke models, and only 50% (TBI) or 10-20% (stroke) of rats develop spontaneous seizures (Loescher and Brandt, 2010) . This is a strikingly lower incidence compared with post-SE models in which over 90% of rats develop epilepsy. However, SE is only a relatively rare cause of symptomatic epilepsy in humans. The long latent period and low percentage of rats developing epilepsy after stroke are the main disadvantages for preclinical studies, aside from even more laborious issues of EEG monitoring for several months. Consequently, no report of antiepileptogenesis study using stroke models is available. Analysis of the key articles on poststroke epileptogenesis shows that very few data support any of the classic models leading to induction of chronic epilepsy (as opposed to short-term seizures). An important point made by Kelly and coworkers in at least two or three articles was that their initial observations of events that they thought were epileptic seizures were in fact spikewave discharges that were readily seen in control animals. Thus, part of this probably reflects the fact that the seizure frequency is extremely low and that the seizures may occur in clusters, so spontaneous epileptic seizures have not been well documented in these models.
Our understanding of the poststroke disease process has benefitted greatly from established acute and chronic models. A combination of multidisciplinary neuroscience approaches involving stroke and epilepsy across sex and age models offers a more well integrated, systems-level approach for addressing key questions in PSE. Although seminal insights and treatments have been identified from conventional rodent stroke models, many limitations of these rodent models preclude effective advancement toward PSE modeling and validation of the therapeutic targets. Despite striking sex differences in stroke incidences, most PSE studies continue to be implemented in male animals. Embracing new technologies including rodent imaging and neuronal epigenome technology may provide a broader approach to PSE modeling for pathology studies and drug discovery. Although tedious and with limited success rates, embracing a wide range of animal models is helpful in our pursuit of a better understanding of the epileptogenic process triggered by ischemic and hemorrhagic strokes.
